| Alkem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539523 |
NSE Symbol : ALKEM |
P/E(TTM) : 30.42 |
|
ISIN Demat : INE540L01014 |
Div & Yield% : 0.79 |
EPS(TTM) : 187.01 |
|
Book Value(₹) : 1,142.87 |
Market Cap(₹Cr) : 68,024.12 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 8,831.13 | 7,972.25 | 9,054.55 | 8,829.81 | 7,219.68 |
| Other Income | 698.23 | 492.63 | 266.29 | 199.89 | 190.01 |
| Stock Adjustments | -56.61 | 30.85 | -257.73 | 360.90 | 301.29 |
| Total Income | 9,472.75 | 8,495.73 | 9,063.11 | 9,390.60 | 7,710.98 |
| EXPENDITURE : | |||||
| Raw Materials | 2,785.53 | 2,654.63 | 3,572.91 | 3,926.79 | 2,966.31 |
| Power and Fuel Cost | 128.35 | 123.85 | 126.32 | 129.53 | 100.12 |
| Other Manufacturing Expenses | 509.57 | 439.03 | 361.12 | 399.80 | 280.51 |
| Selling and Administration Expenses | 1,339.94 | 1,310.79 | 1,739.71 | 1,438.80 | 1,007.42 |
| Miscellaneous Expenses | 131.84 | 307.17 | 103.59 | 50.94 | 71.74 |
| Employee Benefit Expenses | 1,723.09 | 1,560.28 | 1,516.22 | 1,434.49 | 1,158.72 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 2,854.43 | 2,099.98 | 1,643.24 | 2,010.25 | 2,126.16 |
| Interest | 76.11 | 80.07 | 86.40 | 37.90 | 42.93 |
| Gross Profit | 2,778.32 | 2,019.91 | 1,556.84 | 1,972.35 | 2,083.23 |
| Depreciation | 283.61 | 239.14 | 229.85 | 218.98 | 198.93 |
| Profit Before Tax | 2,494.71 | 1,780.77 | 1,326.99 | 1,753.37 | 1,884.30 |
| Current Tax | 261.10 | 32.82 | 227.52 | 303.82 | 331.83 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -47.28 | 0.80 | -35.00 | -91.70 | -132.61 |
| Reported Net Profit | 2,280.89 | 1,747.15 | 1,134.47 | 1,541.25 | 1,685.08 |
| Extraordinary Items | 4.20 | -57.92 | -10.24 | 1.82 | 16.49 |
| Adjusted Net Profit | 2,276.69 | 1,805.07 | 1,144.71 | 1,539.43 | 1,668.59 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 8,640.88 | 7,431.77 | 6,823.39 | 5,700.62 | 4,350.32 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 502.17 | 538.04 | 526.09 | 418.48 | 334.78 |
| P & L Balance carried down | 10,419.60 | 8,640.88 | 7,431.77 | 6,823.39 | 5,700.62 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 2,250.00 | 2,000.00 | 2,500.00 | 1,700.00 | 1,500.00 |
| Dividend Per Share(Rs) | 45.00 | 40.00 | 50.00 | 34.00 | 30.00 |
| Earnings Per Share-Unit Curr | 190.79 | 146.14 | 94.90 | 128.92 | 140.95 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 1,030.68 | 882.86 | 782.09 | 731.38 | 637.87 |
| Book Value(Adj)-Unit Curr | 1,030.68 | 882.86 | 782.09 | 731.38 | 637.87 |